FDA agreed that data from the Phase 2a diSArm study support advancement of AP-SA02 to a Phase 3study First bacteriophage company to advance a clinical candidate to ...
Antimicrobial resistance and ecological disruption caused by broad-spectrum disinfectants have created an urgent need for ...
Detailed price information for Armata Pharmaceuticals Inc (ARMP-A) from The Globe and Mail including charting and trades.
Armata Pharmaceuticals, Inc. ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the ...
Researchers have developed a sunlight-activated nanospray that can rapidly kill drug-resistant bacteria, stop bleeding and relieve pain, significantly accelerating the healing of infected diabetic ...
The Punch on MSN
Why gonorrhoea, staph infections are drug-resistant – Experts
Experts warn that antibiotic misuse is fueling drug-resistant infections like gonorrhoea and staph, making them harder to ...
In this video interview, Peter A. Lio, MD, clinical assistant professor of dermatology and pediatrics at the Northwestern ...
A recent study found permanent pacemaker infection (PPMI) in 2.09% patients, with infections more prevalent in devices ...
3d
Ciprofloxacin, a common antibiotics, becomes ineffective in majority of cases, finds SMS Hosp study
Bacteria learned to survive by developing their own defence mechanism against antibiotic use, finds a 2025 study report by ...
Retrospective data from Southern Italy show a marked rise in pediatric septic head and neck infections, with greater severity ...
The rise of antibiotic resistance has renewed interest in bacteriophages as therapeutic alternatives. However, co-evolution of phage and bacteria will naturally give rise to phage-resistant pathogens, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback